InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-8.8%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by BLACKFORD GARY, Director. Director active across 3 companies, notably ReShape Lifesciences Inc.. Aggregated, 8 disclosures have been recorded. Activity tracked since 22 July 2021. The latest transaction was disclosed on 2 January 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations8 total
12,003 shares0Common StockSEC:0001606498-25-000016:0
8,378 shares0Common StockSEC:0001606498-24-000013:0
7,008 shares0Common StockSEC:0001606498-23-000006:0
5,354 shares0Common StockSEC:0001606498-22-000007
5,354 shares0Common StockSEC:0001606498-22-000007:0
253,429 shares0Common Stock, $0.001 par value per shareSEC:0001790300-21-000008:0
253,429 shares0Common Stock, $0.001 par value per shareSEC:0001790300-21-000008
4,274 sharesCommon StockSEC:0001209191-16-089552:0
8 of 8 declarations
About BLACKFORD GARY
Gary Blackford is a Board Member at ReShape Lifesciences Inc. and Avanos Medical, Inc. He brings expertise in business strategy and product development to the board. His role involves overseeing growth initiatives and ensuring that operations align with the company's goals.
